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Background:Norbormide (NRB) is a selective rat toxicant endowedwith vasoconstrictor
activity confined to the rat peripheral arteries. In a recent work we used a fluorescent
derivative of NRB (NRB-AF12), obtained by coupling the NBD fluorophore to the parent
molecule via a linker, in order to gain information about the possible site of action of the
unlabeled compound. We found that NRB-AF12 labeled intracellular organelles in both
NRB-sensitive and -insensitive cells and we accordingly proposed its use as a scaffold
for the development of a new class of fluorescent probes. In this study, we examined
the fluorescent properties of a BODIPY FL-conjugated NRB probe (MC009) developed:
(A) to verify if NRB distribution could be influenced by the attached fluorophore; (B) to
improve the fluorescent performance of NRB-AF12.
Methods: MC009 characteristics were investigated by confocal fluorescence
microscopy, in freshly isolated rat caudal artery myocytes (FIRCAM) and in LX2 cells,
representative of NRB-sensitive and insensitive cells, respectively.
Main results: In both FIRCAM and LX2 cells MC009 stained endoplasmic reticulum,
mitochondria, Golgi apparatus and lipid droplets, revealing the same intracellular
distribution as NRB-AF12, and, at the same time, had both improved photostability and
gave a more intense fluorescent signal at lower concentrations than was possible with
NRB-AF12, which resulted in a better and finer visualization of intracellular structures.
Furthermore, MC009 was effective in cellular labeling in both living and fixed cells. At the
concentration used to stain the cells, MC009 did not show any cytotoxic effect and did
not affect the regular progression of cell cycle and division.
Conclusions: This study demonstrates that the distribution of fluorescently labeled
NRB is not affected by the type of fluorophore attached to the parent compound,
supporting the idea that the localization of the fluorescent derivatives may reasonably
reflect that of the parent compound. In addition, we observed a marked improvement in
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the fluorescent properties of BODIPY FL-conjugated NRB (MC009) over its NBD-derived
counterpart (NRB-AF12), confirming NRB as a scaffold for the development of new, high
performance, non-toxic fluorescent probes for the labeling of intracellular structures in
both living and fixed cells.
Keywords: fluorescent probes, live cell imaging, norbormide, BODIPY, vascular smooth muscle cells, LX2 cells
INTRODUCTION
Norbormide (NRB) is a very unique compound characterized
by a species (rat)-, tissue (vascular)-, and stereo (endo isomers)-
specific biological activity that is lethal to rats, in which it
induces a profound and irreversible vasoconstriction that has
been associated to its toxic effect (Roszkowski, 1965; Poos et al.,
1966; Bova et al., 2001; Cavalli et al., 2004; Rennison et al., 2007).
Previous studies indicated that NRB elicits its vasoconstrictor
action by directly interacting with rat vascular myocytes, with
no apparent interaction with the vascular endothelium (Fusi
et al., 2002). The molecular site of action and the mechanisms
involved in the vasoconstrictor effect of NRB are unknown;
however, it can be hypothesized, based on the features of its
biological effect, the existence of a target that is exclusively
expressed in the rat artery myocytes, or one that is part of a family
expressed in the blood vessels of all animal species, but which has
species-selective variants. In this latter case, the identification of
the NRB binding site may potentially lead to the development
of species-selective vasoconstrictors for use as species-selective,
eco-sustainable pesticides or, alternatively, as selective vascular
modulators for use in humans.
In the attempt to identify the cellular location of the NRB
binding site we have recently developed a nitrobenzoxadiazole
(NBD) derivative of NRB (NRB-AF12), and investigated its
distribution in both NRB-sensitive cells, i.e., freshly isolated
rat caudal artery myocytes (FIRCAMs) and NRB-insensitive
cells (D’Amore et al., 2016). The results of our previous work
revealed that in all cell types investigated NRB-AF12 clearly
labeled intracellular structures such as endoplasmic reticulum
(ER), Golgi apparatus, mitochondria and some lysosomes,
without inducing any apparent cytotoxic effect. These findings
suggested that an intracellular target could be involved in
the vasoconstrictor effect of NRB and, at the same time,
indicated NRB as a potential scaffold for the development of
a new class of fluorescent probes for living cells (D’Amore
et al., 2016). Compared to other fluorophores, NBD has the
advantage of being relatively small in size, which theoretically
reduces the risk of it inadvertently modifying the functional
properties of the molecule to which it is conjugated. However,
shortcomings include low quantum yields (that reduces the
brightness of the fluorescent images) and limited photostability
(resulting in the rapid bleaching of the probe on exposure to
UV radiation). By contrast, boron dipyrromethene difluorides
(BODIPYs), which constitute an extensive family of fluorescent
dyes, display many improved photo-physical properties over
their NBD counterparts, including larger absorption coefficients,
higher fluorescence quantum yields, narrower emission profiles,
improved photostability, lower sensitivity to changes in polarity
and pH, and are also available in a broader range of colors
(Karolin et al., 1994; Bergström et al., 2002; Ulrich et al.,
2008). The use of fluorophores to label small molecules, in
order to define their cellular distribution (and the potential
site/s of action), is not without risk since the distribution of
the fluorescent signal may not necessarily reflect that of the
unlabeled compound itself. However, this risk may be reasonably
mitigated by establishing that different derivatives carrying
distinct fluorophores have similar cellular distribution.
In this study, we investigated the biological properties
of a BODIPY FL-conjugated NRB derivative (MC009), and
confirmed that (i) it had the same distribution profile as NBD-
derived NRB-AF12 in NRB-contracted cells; (ii) it showed an
improved fluorescent profile compared to NRB-AF12 with no
apparent cytotoxic effects, indicating NRB as a suitable scaffold
for the development of novel fluorescent probes for the labeling
of cellular structures in both living and fixed cells.
MATERIALS AND METHODS
Ethics Statement
The procedures involving animals were approved by the Animal
Care and Use Ethics Committee of the University of Padova
under license from the Italian Ministry of Health (project
N◦650/2015), and are in compliance with the National and
European guidelines for handling and use of experimental
animals.
Chemistry
The synthesis of MC009 is schematically represented in
Figure 1A. BODIPY FL (3-[4,4-difluoro-5,7-dimethyl-4-bora-
3a,4a-diaza-s-indacene-3-yl]propionic acid) (Gießler et al.,
2010), along with its corresponding N-hydroxysuccinimide
ester, BODIPY FL NHS ester (Sorkin et al., 2017), and
N-2’-aminoethyl-endo-5-(α-hydroxy-α-2-pyridylbenzyl)-7-
(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide
(Rennison et al., 2013) were prepared using literature methods.
A solution of N-2’-aminoethyl-endo-5-(α-hydroxy-α-2-
pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-
2,3-dicarboximide (90mg, 0.16 mmol), BODIPY FL NHS
ester (69mg, 0.18 mmol) and diisopropylethylamine (31 µL,
0.18 mmol) in dichloromethane (5ml) was stirred at room
temperature for 16 h. The mixture was washed with water, the
separated aqueous phase further extracted with dichloromethane
(2 × 10ml), the combined organic layers dried over anhydrous
magnesium sulfate, filtered and the solvent removed in vacuo.
Purification by flash chromatography (petroleum ether/ethyl
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FIGURE 1 | Synthesis, fluorescent spectrum and biological properties of MC009. (A) Scheme illustrating the synthesis of MC009. (B) Excitation and emission spectra
of MC009. (C) Original records showing the contractile effects of KCl 90mM, NRB (endo isomers) 40µM, MC009 40µM, and NRB-AF12 40µM, in rat caudal artery
rings.
acetate, 1:2) afforded BODIPY FL-NRB conjugate MC009 as a
mixture of endo stereoisomers (red solid; 100mg, 0.12 mmol,
75%). 1H NMR (400 MHz, CDCl3) δ 2.22 (3H, s, CH3), 2.50
(3H, s, CH3), 2.51–2.58 (2H, m, NHCOCH2), 3.20–3.72 (8.2H,
m, NHCOCH2CH2, NCH2CH2NHCO, H-2, H-3, W/H-4),
3.83–3.90 (0.8H, m, U/H-1, V/H-1, Y/H-4), 4.08 (0.1H, m,
U/H-4), 4.29 (0.3H, m, V/H-4), 4.42–4.49 (0.6H, m, W/H-1,
Y/H-1), 5.40 (br s, OH), 5.61–5.64 (0.7H, m, V/H-6, Y/H-6),
6.04–6.07 (1H, m, Ar), 6.19 (0.1H, m, U/H-6), 6.23 (0.2H, m,
W/H-6), 6.26 (br s, OH), 6.27 (br s, OH), 6.29–6.31 (1H, m, Ar),
6.36 (m, NH), 6.47 (m, NH), 6.61 (m, NH), 6.75-7.60 (18H, m,
=CH, Ar), 8.36-8.63 (2H, m, αPyr). m/z (ESI+, 70 eV) calcd
for C49H43BF2N6NaO4 [M+Na]
+: 851.3307; found: 851.3335.
RP-HPLC: tR = 12.5, 12.7min (purity λ254nm = >98%) An
RF-HPLC chromatogram and 1H NMR spectrum are reported
in Supplementary Figure 1).
Fluorescence spectra of MC009 (Figure 1B) was obtained by
dissolving the compound in 100% DMSO to obtain a 2mM
stock solution, then diluted in Milli-Q water to reach the
final concentration of 5µM. Analysis of excitation/emission
peaks were evaluated using a Jasco FP6500 spectrofluorometer
(temperature 25◦C; b= 1 cm; λ ex/em: 470/540; sli: 5/10 nm; data
pitch 0.2 nm; scanning speed 200 nm/min).
Cell Culture
LX2 (a kind gift from Prof. S. Fiorucci, University of Perugia)
cells were cultured at 37◦C in an atmosphere of 5% CO2 in
Dulbecco’s Modified Eagle Medium (Euroclone-Milan, Italy)
supplemented with 10% Fetal Bovine Serum (FBS) (Euroclone),
2mM L-Glutamine and antibiotics (penicillin/streptomycin).
Vascular Smooth Muscle Cells (VSMCs)
Isolation
VSMCs were isolated from the tail main artery of male Wistar
rats and C57BL/6 mice as previously reported (Fusi et al., 2002).
Briefly, a 5-mm long piece of artery (rat) or the whole artery
(mice) were incubated at 37◦C for 40–45min in 2ml of 0.1mM
Ca2+ external solution containing 20mM taurine, 1.35 mg/ml
collagenase (type XI), 1 mg/ml soybean trypsin inhibitor, and
1 mg/ml BSA, which was lightly bubbled with a 95% O2 – 5%
CO2 gas mixture to gently agitate the enzyme solution. Cells
were stored in 0.1mM Ca2+ external solution (NaCl 110mM,
KCl 5.6mM, D-glucose 20mM, taurine 20mM, Hepes 10mM,
Na pyruvate 5mM, MgCl2 1.2mM, BSA 0.5 mg/ml; pH 7.35)
at 4◦C under normal atmosphere for at least 1 h, and were
used for experiments within 1 day following isolation; the same
solution was used as incubation medium during the experiments
involving these cells, as previously reported (Fusi et al., 2002).
Live Cell Imaging
To define the cellular distribution of MC009 in living
rats and mice VSMCs, cells were incubated with MC009
(100 nM) for 30min in a humidified 5% CO2 incubator
at 37◦C. In separate experiments, cells were loaded with
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MC009 plus CellMaskTM (1:5,000), a fluorescent probe for
plasma membrane, or with the fluorescent Ca2+ indicator X-
Rhod-1TM (1–2.5µM). MC009 concentration (100 nM) and its
loading protocol were chosen on the basis of preliminary
experiments performed in LX2 cells, and is described in the
results section. In living LX2 cells MC009 distribution was
studied by loading it alone (10–100 nM) or in combination
with fluorescent probes selective for intracellular structures: ER
TrackerTM red (500 nM), a marker of endoplasmic reticulum,
pHrodoTM (50 ng/ml), a marker of endosomes and lysosomes,
LipidTOXTM (1:1,000), a marker of lipid droplets. Mitochondria
ER distribution of MC009, were further investigated in LX2
cells transfected with COX-IV-RFP-pcDNA3.1 or calreticulin-
RFP-pcDNA3.1 plasmids using Lipofectamine LTX reagent
(Invitrogen), according to manufacturer’s instructions. 24 h post
transfection, cells were left untreated or primed with thapsigargin
(5µM) for 3 h to induce acute intracellular stress and swelling of
the organelles, and finally loaded using MC009 (100 nM).
The distribution of MC009 was also investigated both during
and after cell division. To this end, LX2 cells were chemically
synchronized in the G2/M phase through exposure to RO-
3306 (10µM) for 18 h, with MC009 (1µM) in the culture
medium. Following treatment, cells were washed with reagent-
free medium and the cell cycle was reinduced through the
addition of 10% FBS. Cellular distribution of MC009 and cell
division were monitored at 30min intervals for 4 h.
Immunocytochemistry
In order to evaluate MC009 co-localization with Golgi apparatus,
2 × 104 LX2 cells were plated onto 12mm coverslips and left to
attach for 24 h. Cells were then fixed with 0.25% glutaraldehyde
in 0.1M sodium cacodylate, pH 7.4 for 5min and permeabilized
using 0.1% digitonin for 10min; cells were incubated with
GM130 antibody (1:500) for 90min at room temperature.
Following PBS washes, cells were fluorescently labeled with
Cy3 goat anti-rabbit IgG fluorescent secondary antibody (1:500
for 60min at room temperature) in the presence of MC009
100 nM. Finally, coverslips were mounted on microscope slides
using Mowiol 40–88 (Sigma Aldrich) and images acquired under
confocal microscope. In separate experiments cells were fixed
using ice-cold methanol instead of glutaraldehyde.
Contraction of Rat Caudal Artery Rings
The contractile activity ofMC009 was evaluated in rings obtained
from the ventral caudal artery of Wistar rats as previously
described (Bova et al., 2001). Briefly, the rings, cleaned of
the adventitia, were mounted in a home-made myograph by
inserting two 100µm thick tungsten wires into their lumen
and immersed in 15ml double-jacketed organ baths containing
a salt solution of the following composition: NaCl 125mM,
KCl 5mM, MgSO4 1mM, KH2PO4 1.2mM, CaCl2 2.7mM,
NaHCO3 25mM and glucose 10mM, bubbled with a mixture
of O2 (95%) and CO2 (5%) and maintained at 37
◦C at a pH of
7.35. The contractile force was measured through an isometric
force transducer (2B Instruments, Milano, Italy) coupled to an
analog-to-digital converter (PowerLab). At the beginning of the
experiment, a preload of 3 g (1 g/mm) was applied to each ring.
The preloaded rings were left to equilibrate for at least 60min
and then repeatedly stimulated with 90mM KCl and 10µM
phenylephrine until two consecutive reproducible contractile
responses to each stimulus were obtained. The experiments were
conducted in rings mechanically deprived of the endothelium;
the absence of a functional endothelium was confirmed by the
lack of carbachol-induced relaxation of rings pre-contracted with
phenylephrine.
MC009 Cellular Uptake
To evaluate the effect of endocytosis on MC009 uptake, LX2
cells were plated onto 12mm coverslips and left to attach for
24 h. The cells were maintained at 4◦C for 30min to inhibit
endocytosis and then treated with 80µMDynasore (an inhibitor
of dynamin-dependent endocytosis) (Kirchhausen et al., 2008)
for 30min at 37◦C, after whichMC009 (100 nM)was added to the
culture medium for an additional 30min. pHrodo red transferrin
conjugate (25µg/ml), which is known to enter the cells via
dynamin-dependent, dynasore-sensitive endocytosis, was used
under the same conditions as a positive control. At the end of
the incubation period cells were washed with PBS, rinsed with
probe-free medium and immediately observed under confocal
microscopy using a 40× objective. Quantification of fluorescence
was performed with Fiji software using the following formula:
Corrected Total Cell Fluorescence (CTCF) = Integrated density
- (Cell area x Mean of fluorescence of background readings)
and reported as percentage relative to the CTRL (McCloy et al.,
2014).
MTT Assay
LX2 cells were seeded (1.5 × 103 cells/well) in 96-well tissue
plates and exposed to increasing concentrations of MC009
(0.01, 0.1, 1, 10, and 50µM) for 24 h. Cellular growth was
evaluated by MTT reduction assay (Mosmann, 1983; Di
Francesco et al., 2015). Briefly, at the end of the experiment,
20 µl of a sterile solution of tetrazolium salt (5 mg/ml in
PBS) were added to each well, and following 4 h at 37◦C the
supernatant was discarded and the resultant formazan crystals
were dissolved in 200 µl of dimethyl sulfoxide. Absorbance
intensity was measured at 570 nm on a multi-well plate
spectrophotometer (VICTORTMX3 2030 Multilabel Reader,
Perkin Elmer).
Confocal Microscopy
Fluorescent images were collected using a Zeiss Axio Observer Z1
inverted confocal microscope equipped with a Plan-Apochromat
63×/1.40 Oil DIC objective. For live imaging experiments, cells
were maintained in an atmosphere of 5% CO2 and warmed at
37◦C in a heated chamber.
Sources of Fluorescent Probes, Antibodies
and Chemicals
CellMaskTM (#C10045), X-Rhod-1TM (#X14120), ER TrackerTM
red (#E34250), pHrodoTM (#P10361), LipidTOXTM (#H34477)
and pHrodo red transferrin conjugate (#P35376) were obtained
from Thermo Fisher Scientific. Dynasore and Ro-3306
were purchased from Abcam, Lipofectamine LTX reagent
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from Invitrogen, Anti-GM130 antibody (#610822) from BD
Biosciences and Cy3 goat anti-rabbit IgG fluorescent secondary
antibody (#111-165-003) from Jackson ImmunoResearch.
Hazards Related to the Use of NRB and Its
Derivatives for Research Purposes
In HSNO (Hazardous Substances and New Organisms) terms, a
substance is considered hazardous if it triggers any one of the
threshold levels for any of the hazardous properties listed in the
USA Environmental Protection Agency (EPA) guidelines, one of
which is toxicity. NRB is extremely toxic to rats and as such is
classified as an “extremely hazardous chemical” in the US and
elsewhere. However, one of the key features of NRB is that its
toxic activity is uniquely restricted to rats, having little or no
activity in any other species tested (including humans). In fact,
NRB’s lethal activity is even further restricted as it seems only
to be toxic to species within the Rattus genus, with other rat
genera being little or not affected. Consequently, both NRB and
the NRB derivatives reported in this research paper pose little or
no hazard to the researchers, and as such no special conditions
or safety precautions are required to work with these substances
other than those required to conform to standard laboratory
practices.
Statistical Analysis
All values are expressed as means ± standard error mean
(SEM) of n observations/group. Analysis of all the images
and the computation of the Pearson’s coefficients of co-
localization were performed using the open-source platform
for biological-image analysis Fiji software. Comparison of two
groups was obtained by the Student’s t-test for unpaired data
where appropriate. Comparison of more than two groups
were made with one-way ANOVA using post-hoc Tukey’s test.
Differences were considered statistically significant at values of
P < 0.05.
RESULTS
MC009 Fluorescence Spectrum and
Vasoconstrictor Activity
By analysing the excitation and emission peaks at 500 and
511 nm, respectively, we were able to confirm that the fluorescent
spectrum of MC009 overlapped with that of the parent BODIPY
FL fluorophore (Figure 1B).
Given MC009 is a BODIPY-conjugate of the endo
(contracting) isomers of NRB, we tested its effect on rat
caudal artery rings (RCAr) to verify if the compound retained
the vasoconstrictor properties of the parent NRB. As reported
in Figure 1C, MC009 contracted RCAr, although with less
effectiveness when compared to NRB itself, with the contractile
effects of NRB and MC009 (expressed as percent of the 90mM
KCl-induced contraction) being 140 and 50%, respectively.
NBD-derived NRB-AF12 likewise showed a contractile effect
in RCAr, with an effectiveness equivalent to 70% of that
induced by KCl (Figure 1C). A concentration of 40µM was
chosen for both compounds in these experiments because at
higher concentrations MC009 precipitated from the incubation
medium.
MC009 Loading Procedures in Living and
Fixed LX2 Cells
Preliminary experiments were carried out to establish the
most optimum experimental parameters (with regard to
both compound concentration and loading procedure) which
would facilitate the best visualization of MC009 intracellular
fluorescence distribution in living cells. The experiments were
performed in human cultured hepatic stellate cells (LX2 cells),
the same cell line that was previously used to characterize
the intracellular fluorescence distribution of NBD-derivative
NRB-AF12 (D’Amore et al., 2016). The results indicated that
the best defined images of the intracellular organelles could
be attained by incubating the cells with 100 nM MC009 for
30min at 37◦C (Figure 2A); however, an acceptable fluorescent
signal could also be achieved using lower concentrations of the
probe, i.e., 50 nM (Figure 2B) and 10 nM (Figure 2C). MC009
concentrations higher than 100 nM did not lead to a significant
improvement in image quality (data not shown). The time-
course of the cellular uptake of MC009 was characterized by
collecting a single focal plan video of LX2 cells exposed to 100 nM
MC009 (Supplementary Video 1). The results, summarized in
Figure 2D, indicate that following the addition of the fluorescent
dye to the incubation medium, the labeling of intracellular
structures was detectable within 60 s, was clearly evident within
5min and reached a plateau at 30min. Higher concentrations
(>100 nM) and/or longer incubation times did not significantly
ameliorate the quality of the fluorescent images (data not shown).
MC009 uptake was not affected by dynasore, an inhibitor of
dynamin-dependent endocytosis, suggesting that its entry is
not related to endocytotic processing; in contrast, under the
same experimental conditions, dynasore significantly reduced
transferrin uptake, which is known to be a dynamin-dependent
process (Figures 2E,F). We also investigated the retention time
ofMC009, evaluated as fluorescence intensity, in LX2 cells loaded
with the probe (100 nM for 30min) and then incubated in a
probe-free medium and imaged every 15–30min. The results,
summarized in Figure 2G, indicate that a clear staining of
intracellular organelles could be detected for at least 90min
following removal of the fluorescent dye from the incubation
medium.
Images of fixed LX2 cells incubated with 100 nM
MC009 were comparable to those obtained in living cells
(Supplementary Figure 1A), although the fluorescence signal
was not well retained post-permeabilization and was significantly
reduced due to the numerous washings required during the
immunocytochemistry experimental procedure. The comparison
of different fixation-permeabilization protocols indicated that
the best results could be obtained using cross-linking fixative
reagents (i.e., 0.25% glutaraldehyde) that preserve cell structures;
in contrast, fixation of cells with methanol, which in addition
to precipitating proteins removes lipids from the cells, resulted
in low-defined images of intracellular structures by MC009
(Supplementary Figures 2A,B).
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FIGURE 2 | MC009 distribution and kinetics of internalization in living LX2 cells. Confocal live imaging of LX2 cells labeled with MC009 (A) 100 nM, (B) 50 nM, and (C)
10 nM, showing subcellular distribution of the probe. Magnification 63×; scale bar 10µm. (D) MC009 internalization in LX2; data reported was extrapolated from a
time-lapse of LX2 cells exposed to MC009 100 nM and imaged every 30 s at a single focal plan for about 30min. (E) Effects of dynasore on the internalization of
MC009 or pHrodo Red Transferrin-conjugate (used as positive control). Magnification 40×; scale bar 20µm. (F) Quantification of fluorescent signal reported as
percentage of CTRL. Data reported represent mean ± SEM; *p < 0.05 vs. CTRL; n ≥ 150 cells. (G) LX2 cells were incubated for 30min with MC009; after replacing
the staining solution with probe-free medium, evaluation of MC009 extent of fluorescent signal was performed.
MC009 Distribution in LX2 Cells
In order to establish if the conjugation of different fluorophores
to NRB could influence its cellular distribution, we compared the
distribution of MC009 and NRB-AF12 in LX2 cells. Since the two
fluorescent dyes have not widely differing excitation/emission
spectra (NRB-AF12 ex/em: 470/540 D’Amore et al., 2016;
BODIPY FL ex/em: 502/511), a direct co-localization study was
not possible. As a consequence, we used ER-TrackerTM red as
an NRB-AF12 surrogate based on the finding that NRB-AF12
and ER TrackerTM red have identical distribution intracellularly
(D’Amore et al., 2016). Our results, reported in Figures 3A,B
and Tables 1, 2 clearly show that both NRB-AF12 and MC009
fluorescence overlapped with that of ER-tracker, strongly
supporting the idea that, despite bearing different fluorophores,
MC009 and NRB-AF12 label the same intracellular structures. Of
note is the lack of plasma membrane staining by both MC009
and NRB-AF12, and a well-defined localization of both dyes to
intracellular structures that have been previously identified as
targets for NRB-AF12, e.g., ER, mitochondria, Golgi apparatus
endosomes and lysosomes (D’Amore et al., 2016). To confirm
that MC009 and NRB-AF12 bound to the same intracellular
organelles, MC009 was used in combination with various
fluorescent probes and/or antibodies that specifically target the
NRB-AF12-labeled intracellular structures. The distribution of
MC009 to ER was evaluated by transiently transfecting LX2
cells with a plasmid expressing the luminal ER resident protein
calreticulin-RFP, and then loading the cells with the fluorescent
dye. The results, reported in Figure 3C and in Table 1, show
that MC009 fluorescent signaling significantly overlaps with that
of calreticulin-RFP (Pearson’s Coefficient: 0.65 ± 0.09; n ≥
10). The binding of MC009 to ER did not apparently affect
its organization and continuous remodeling, as shown in the
Supplementary Video 2.
The potential for mitochondrial localization of MC009 was
investigated in living LX2 cells transiently transfected with
COX-IV-RFP plasmid to visualize the mitochondrial membrane
resident protein COX-IV. As depicted in Figure 4A, and as
reported in the computation of the Pearson’s index of co-
localization (Table 1), MC009 clearly labeled mitochondria. To
assess whether MC009 bound the mitochondrial membrane,
COX-IV-RFP transiently transfected cells were treated with
thapsigargin to induce mitochondrial swelling (Korge and
Weiss, 1999). Confocal images indicate a strong labeling of
the mitochondrial membrane by MC009 (Figure 4B), a result
that was confirmed in LX2 fixed cells labeled with MC009
and immunostained for COX-IV (Supplementary Figure 3). To
verify whether MC009 bound the Golgi apparatus, LX2 fixed
cells were immunostained with antibodies directed against the
Golgi structural protein GM130 (α-GM130). The results, shown
in Figure 5A, indicate a co-localization of MC009 and α-GM130
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FIGURE 3 | Endoplasmic reticulum markers and MC009 co-localization in living LX2 cells. Representative live cells microphotographs showing co-localization
between (A) NRB-AF12 and (B) MC009 with ER-TrackerTM in LX2 cells. (C) Live cell imaging of liver hepatic stellate cells transfected with the ER marker
calreticulin-RFP and then stained using MC009. For each image, merged fluorescence is shown in right panel. Magnification 63×; scale bar 10µm.
TABLE 1 | Computation of Pearson’s co-localization coefficient between MC009
and fluorescent probes/protein/antibodies targeted to specific subcellular
structures (i.e., ER TrackerTM, COX-IV-RFP, calreticulin-RFP, α-GM130,
pHrodoTM, LipidTOXTM, Cell MaskTM, and X-Rhod 1TM).
MC009 Pearson’s Coeffficient (mean ± SEM)
ER TrackerTM 0.96 ± 0.03
COX IV_RFP 0.46 ± 0.14
Calreticulin_RFP 0.65 ± 0.09
GM130 0.31 ± 0.07
Lipid TOXTM 0.22 ± 0.08
pHrodoTM 0.08 ± 0.04
CellMaskTM −0.07 ± 0.1
X-Rhod 1TM 0.69 ± 0.15
All values are expressed as means ± SEM; n ≥ 10.
TABLE 2 | Quantification of NRB-AF12 and ER-Tr co-localization is shown as
Pearson’s coefficient; data are reported as means ± SEM; n ≥ 10.
AF12 Pearson’s Coeffficient (mean ± SEM)
ER TrackerTM 0.95 ± 0.02
(Pearson’s coefficient: 0.31 ± 0.07; n ≥ 10), confirming that
MC009 partially overlapped with Golgi apparatus markers.
Binding to the vesicles of endocytic pathway (i.e., endosomes and
lysosomes) was investigated by co-staining LX2 cells withMC009
and the commercially available fluorescent probe pHrodoTM,
which has been previously demonstrated to stain organelles
involved in endocytosis (D’Amore et al., 2016). As shown in
Figure 5B, there was in general no co-localization between the
two fluorescent dyes (Pearson’s index: 0.08 ± 0.04); however, a
deeper analysis of the confocal images revealed that a few vesicles
were positive for MC009 staining.
Finally, we observed a localization of MC009 in spherical
particles that were identified, by incubation with the fluorescent
probe LipidTOXTM, as lipid droplets, i.e., the intracellular sites for
neutral lipid storage (Figure 5C).
MC009 Toxicology in LX2 Cells
The cytotoxicity of MC009 was assessed by priming LX2 cells
with increasing doses (ranging from 10 nM to 50µM) over a
24 h period; results obtained from MTT assays revealed that the
fluorescent dye is non-toxic to the cells, even at concentrations
much higher than those needed for cell staining (Figure 6A).
In addition, we investigated the distribution of MC009
during mitosis in LX2 cells. To this end, cells were chemically
synchronized at the G2/M transition by exposing them to 10µM
RO-3306, an inhibitor of cyclin-dependent kinase 1 activity, and
then loaded withMC009. Mitosis and cell cycle was then restored
by incubating cells with RO-3306-free medium supplemented
with FBS 10%, and the intracellular distribution of fluorescence
was monitored for 4 h. In mitotic LX2 cells, MC009 distribution
was confined to the perinuclear region, the majority of the signal
being excluded from the spindle region, whereas a fraction of
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FIGURE 4 | Mitochondrial markers and MC009 co-localization in living LX2 cells. Confocal live cell imaging of LX2 cells transfected with COX-IV-RFP plasmid and
subsequently stained with MC009; cells were (A) left untreated or (B) primed with thapsigargin. Insets show magnification of the pictures. Magnification 63×; scale
bar 10µm.
the MC009 fluorescence was visualized close to the spindle poles.
As shown in Figure 6B, MC009 is transferred to daughter cells
and a gradual recovery of a reticular appearance occurs following
cellular division.
MC009 Distribution in FIRCAMs
Figure 7A is an image of a FIRCAM loaded with MC009.
FIRCAMs represent the major cell type that are sensitive
to NRB, responding to NRB application with a rapid
and irreversible contraction (Fusi et al., 2002). The image
highlights a clear labeling of intracellular structures with no
apparent localization in the cytoplasmic milieu (Figure 7A and
Supplementary Video 3). The fluorescent structures consist
of some central elements and a sub-plasmalemmal network
that coincide with intracellular calcium stores, as visualized by
counterstaining the cell with the low-affinity calcium indicator X-
Rhod-1TM (Figure 7B) or CellMaskTM (Figure 7C), a fluorescent
probe used for the staining of plasma membrane. The figure also
shows that MC009 fluorescence distribution strongly co-localizes
with that of X-Rhod-1 (Pearson’s coefficient: 0.69 ± 0.15), but
not with that of CellMaskTM (Pearson’s coefficient: −0.07 ± 0.1),
revealing that MC009 distribution in these cells replicates that
observed in LX2 cells. Quite similar results were obtained in
VSMCs isolated from mouse caudal artery, which are insensitive
to NRB (Supplementary Figure 4).
DISCUSSION
MC009 as a New Prototype Fluorescent
Tool for Visualizing Intracellular Structures
in Living Cells
The use of fluorescent probes for live cell imaging represents
an important technique to observe and monitor a plethora of
biological processes, such as morphological cellular changes,
activity and remodeling of intracellular structures, membrane
trafficking and vesicle formation. Being able to conduct such
studies on living cells avoids the artifacts or cell alterations that
can often occur during the cell fixation process. One of the main
advantages of live cell imaging is the capacity to dynamically
observe over time all of these biological processes in a non-
invasive manner, without alteration or interference in any way,
provided that the probes are endowed with good photostability,
long-term tracing, high signal-to-noise ratio, and a lack of cell
toxicity.
In this study we show that conjugation of the BODIPY FL
fluorophore to NRB afforded a compound (MC009) endowed
with excellent fluorescent properties, coupled with a lack
of cytotoxicity, that make it a suitable tool for living cell
imaging. Compared to NRB-AF-12, an NBD-derived NRB
fluorescent probe, MC009 shows lower photo-bleaching, better
stability of the fluorescent signal, and better demarcation of the
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FIGURE 5 | Golgi, endosomes, lysosomes and lipid droplets markers co-localization with MC009. (A) LX2 fixed cells immunostained for the Golgi apparatus structural
protein GM130; cells were counter-labeled with MC009. (B,C) MC009 labeled LX2 cells counterstained with (B) the fluorescent dye for endosomal and lysosomal
compartments or (C) for lipid droplets. Magnification 63×; scale bar 10µm.
labeled structures obtained at concentrations lower than those
required for NRB-AF12 (10–100 nM vs. 500 nM). MC009 cellular
internalization was relatively fast and apparently not mediated
by endocytosis, allowing an optimal staining of intracellular
organelles following a few minutes of incubation. Moreover,
a bright fluorescent signal of MC009 was retained for at
least 90min following its removal from the culture medium,
and it is plausible that this signal could be retained much
longer after washout, enabling more extended observations
to be possible (Figure 2). In living LX2 cells MC009 allows
a clear visualization of the ER network, mitochondria and
the Golgi apparatus, likely as a consequence of a greater
concentration of the fluorescent probe in these structures,
in which it seems to target the membranes rather than to
accumulate inside the lumen (Figures 4B, 7B). Of note, MC009
did not apparently disturb the physiological dynamic of either
ER or mitochondria (Supplementary Video 2), as there were
no alterations observed in their morphology (Figures 3, 4),
indicating that the fluorescent dye is well tolerated by the cells.
As previously reported for NRB-AF12 (D’Amore et al., 2016),
MC009 also demonstrated a great biocompatibility, showing
no signs of cellular toxicity, as detected by cell viability tests,
even when the cells were exposed for 24 h at concentrations
as high as 50µM. In addition, MC009 did not impair the
regular progression of cell division (Figure 6B), allowing a
detection of the ER and mitochondria dynamics during mitosis.
Another interesting feature of MC009 is the possibility to
label cellular structures in fixed cells. In this regard, we found
that the best results could be obtained by using cross-linking
fixative reagents, which allowed us to obtain confocal images
comparable with those obtained in living cells (Figure 2 and
Supplementary Figure 2).
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FIGURE 6 | MC009 biocompatibility in LX2 cells. (A) Biocompatibility of MC009 was evaluated by MTT reduction assay. LX2 cells were treated for 24 h with increasing
doses (0.01–50µM) of MC009. Results are relative to untreated cells, that were arbitrarily set to 1. Data reported represent the mean ± SEM of three independent
experiments. Statistical analysis of the MTT data by one-way ANOVA revealed no-significative differences between all groups. (B) MC009 biocompatibility with cell
cycle progression. LX2 cells, chemically synchronized in G2/M by RO-3306, were imaged by confocal microscope after the re-induction of cell division by exposure to
10% FBS; images were acquired every 30min at a single focal plan for 4 h. Magnification 63×; scale bar 10µm.
FIGURE 7 | MC009 distribution in FIRCAMs. (A) Confocal live imaging of a FIRCAM fluorescently labeled with MC009 100 nM. In live imaging of rat primary vascular
smooth muscle cells labeled with MC009 and counterstained with (B) the calcium indicator X-Rhod-1TM or (C) the florescent probe for plasma membrane
CellMaskTM. Insets show magnification of the pictures. Magnification 63×; scale bar 5µm.
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Given the intracellular distribution of the two NRB
fluorescent conjugates used in this study remained unaffected
on changing the fluorophore, it is reasonable to assume that
the parent NRB could be readily modified through conjugation
with other fluorophores, such as those belonging to the
boron-dipyrromethene difluoride family that have different
excitation/emission spectra (i.e., BODIPY TMR, BODIPY TR
and others), without altering its labeling properties. If achievable,
this would enable the creation of a new class of NRB-derived
fluorescent dyes, excitable at different wavelengths to those
currently available, consequently expanding the range of probes
that can be used for live cell imaging. In addition, MC009 did
not interfere with other dyes (i.e., ER TrackerTM, LipidTOXTM,
or pHrodoTM) when used simultaneously for living cell staining
of LX2 cells, excepted for the co-incubation with MitoTrackerTM,
which resulted in mitochondria toxicity as demonstrated by a
rapid swelling of the organelles (data not shown).
MC009 as a Tool to Identify the Cellular
Target of NRB in FIRCAMs
The results of this study show that in living FIRCAMs MC009
targets the membranes of intracellular structures but does not
bind to the plasma membrane (Figure 3), as verified by the lack
of co-localization of MC009 and CellMaskTM (Figure 7C). In
particular, we show a clear binding of MC009 to sarcoplasmic
reticulum (SR) and mitochondria, as previously reported for
NRB-AF12 in the same cells (D’Amore et al., 2016), that leads to
the conclusion that, in NRB-sensitive cells also, the distribution
of the fluorescent derivatives of NRB is not affected by the
type of fluorophore attached to the parent molecule. This
finding, together with the observation that both NRB-AF12 and
MC009 (present study) partly retain the capacity of the parent
compound to induce contraction in rat caudal artery rings,
supports the hypothesis that the distribution of the fluorescent
NRB-conjugates reflects that of NRB itself, making it possible that
the vasoconstriction activity of NRB could be mediated through
an intracellular binding site.
The species-selectivity of the vasoconstrictor effect of NRB
prompted us to investigate if the intracellular fluorescent
distribution of MC009 observed in FIRCAMs could differ
from that observed in the vascular myocyte of a NRB-
insensitive species, i.e., the mice. As reported in Figure 7 and
Supplementary Figure 4, there was apparently no difference in
distribution between FIRCAMs and freshly isolated mice caudal
artery myocytes. Furthermore, the fluorescence distribution of
the corresponding exo isomers of MC009, which is not a
vasoconstrictor, was found to be the same as that observed with
the corresponding endo-specific MC009, as used in this study
(S. Bova, personal communication). These results may indicate
that both the endo and exo isomers of NRB bind to the same
intracellular sites in all cell types; however, only in the rat vascular
myocytes does this binding lead to a rise of cytoplasmic free
calcium concentration and contraction. Another possibility is
that MC009 distribution does not necessarily reflect that of the
parent molecule. It has been reported that the parent BODIPY
FL itself can bind to intracellular lipids, thus influencing the
distribution of the molecule to which it is attached (Courtis et al.,
2014). Such a scenario can be observed with the antidiabetic agent
glibenclamide, which inhibits plasma membrane KATP channels
targeting their SUR subunits (Proks et al., 2002): its BODIPY
derivative, ER-TrackerTM, does not label the plasma membrane,
as expected (D’Amore et al., 2016). However, inmany other cases,
the fluorescent derivatives of small molecules show a cellular
distribution that is in agreement with the binding sites of the
unlabeled parent compounds, as in the case of thapsigargin
(Shmygol and Wray, 2004; Gómez-Viquez et al., 2010), ryanodin
(Gordienko et al., 2001; Shmygol andWray, 2004; Gómez-Viquez
et al., 2010), ceramide, brefaldine A (Deng et al., 1995; White and
McGeown, 2002) and ouabain (Alonso et al., 2013). In the case of
MC009, a couple of observations make this possibility unlikely:
(1) the distribution of MC009 overlaps that of AF12, in which
NRB is conjugated to an NBD group; (2) MC009 retains the
biological activity of the parent molecule, and therefore it must
bind to the NRB target.
CONCLUSIONS
In conclusion, on the basis of the results of this study, we
hypothesize the rat specific vasoconstrictor effect of NRB to be
mediated by an intracellular target localized on the myocytes of
rat peripheral arteries. In addition, we propose MC009 as a new,
high performance, non-toxic fluorescent probe for the labeling
of intracellular organelles in living cells; modification of the NRB
scaffold, to create new fluorescent probes capable of selectively
labeling different intracellular organelles, represents a stimulating
perspective for the future.
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Supplementary Figure 1 | MC009 RF-HPLC chromatogram and 1H NMR
spectrum. (A) Reverse-phase HPLC [Dionex P680 system using a Phenomenex
Gemini C18-Si column (150 × 4.6mm, 5µm)] data for MC009—eluted using a
gradient of 100:0% A/B to 5:95% A/B over 15min at 1 mL/min; where solvent A
was water (0.1% trifluoroacetic acid) and solvent B was CH3CN (0.1%
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trifluoroacetic acid); with detection at 254 nm. (B) 1H NMR spectrum acquired at
400 MHz in CDCl3.
Supplementary Figure 2 | MC009 distribution in LX2 fixed cells. LX2 cells
stained with MC009 were fixed and imaged by confocal microscopy.
(A) Glutaraldehyde fixed cells; (B) methanol fixed cells. Insets show magnification
of the pictures. Magnification 63×; scale bar 10µm.
Supplementary Figure 3 | Mitochondrial markers and MC009 co-localization in
LX2 fixed cells. LX2 fixed cells immunostained for the mitochondrial membrane
protein COX-IV; cells were counter-labeled with MC009. Scale bar 10 µm.
Supplementary Figure 4 | Distribution of MC009 in mouse vascular smooth
muscle cells. Live imaging of mouse primary vascular smooth muscle cells labeled
with MC009 and counterstained with the calcium indicator X-Rhod-1TM.
Magnification 63×; scale bar 10µm.
Supplementary Video 1 | Time-lapse recording of MC009 internalization in LX2
cells. Cells were exposed to MC009 (100 nM) and imaged every 30 s at a single
focal plan for 25min. Scale bar represents 10µm.
Supplementary Video 2 | MC009 labeling did not affect ER organization and
continuous remodeling. Cells were exposed to MC009 (100 nM) and imaged every
5 s at a single focal plan for 3min. Scale bar represents 3µm.
Supplementary Video 3 | 3D reconstruction of a FIRCAM labeled with MC009.
Magnification 63×; scale bar 5µm.
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